Form 4: Medpace Director Exercises Stock Options, Boosts Common Stock Holdings

Medpace Holdings, Inc. Director Cornelius P. McCarthy III exercised 4,500 stock options at $54.99 per share, increasing his direct beneficial ownership of common stock to 9,887 shares.

Summary

• Cornelius P. McCarthy III, a Director of Medpace Holdings, Inc. (MEDP), executed a transaction on July 18, 2025.
• The transaction involved the exercise of 4,500 stock options at an exercise price of $54.99 per share.
• These options were part of a grant that vested in full on May 14, 2020.
• As a result of the option exercise, McCarthy acquired 4,500 shares of Medpace common stock.
• Following this transaction, McCarthy directly beneficially owns 9,887 shares of Medpace common stock.
• After the exercise, McCarthy retains 1,972 unexercised stock options, which have an expiration date of May 17, 2026.

Sentiment

Score: 6

Explanation: The exercise of stock options by a director is generally a neutral to slightly positive signal, as it increases their direct ownership in the company, aligning their interests with shareholders. It's a routine transaction and does not indicate significant new information about company performance.

Positives

• Director Cornelius P. McCarthy III increased his direct beneficial ownership of Medpace common stock by 4,500 shares, indicating continued alignment with shareholder interests.
• The exercise of options suggests the director sees value in the company's stock at the exercise price of $54.99.

Negatives

• No negative information is explicitly stated.

Risks

• No specific risks are detailed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing reports a past insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction (stock option exercise) and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The transaction increases the director's direct ownership, potentially signaling confidence and aligning interests with other shareholders.

Key Dates

Keywords

Medpace Holdings, MEDP, Cornelius P. McCarthy III, Director, Stock Option Exercise, Insider Transaction, Form 4, Beneficial Ownership, Equity Compensation